EternoGen Aesthetics LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EternoGen Aesthetics LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10452
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EternoGen Aesthetics LLC (EA) a subsidiary of EternoGen LLC, is a clinical stage medical device company which develops and manufactures advanced collagen scaffolds to deliver bio dermal restoration in facial aesthetics. Its portfolio of collagen products include rapid polymerizing collagen (RPC) solution with EDTA and D-Mannitol is injected through a fine gauge needle or micro-cannula forms fibrous scaffold in contact with dermal or subcutaneous tissue gets converted to contour stable matrix which inhibits degradation and infill the scaffold forming natural tissue to support and reinforce the wrinkled skin; CG NanoMatrix harnesses collagen degradation, stimulate tissue regeneration and reduce inflammation formulated to extend duration to around two years. The company markets and distributes its products non-surgical medical aesthetic market. EA is headquartered in Columbia, Missouri, the US.

EternoGen Aesthetics LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EternoGen Aesthetics LLC, Medical Equipment, Deal Details 10
Venture Financing 10
EternoGen Aesthetics to Raise Funds through Venture Financing 10
EternoGen Aesthetics Raises USD5 Million in Venture Financing 11
EternoGen Aesthetics Raises Additional USD0.7 Million in Venture Financing 12
EternoGen Aesthetics Raises USD0.1 Million in Venture Financing 13
Dermelle Raises US$1 Million In Venture Financing 14
EternoGen Aesthetics LLC – Key Competitors 15
EternoGen Aesthetics LLC – Key Employees 16
EternoGen Aesthetics LLC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Jan 04, 2017: EternoGen opens offices at M2D2 18
Corporate Communications 19
Jan 04, 2017: EternoGen opens offices at M2D2 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
EternoGen Aesthetics LLC, Medical Equipment, Key Facts 2
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Deals By Market, 2012 to YTD 2018 8
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EternoGen Aesthetics to Raise Funds through Venture Financing 10
EternoGen Aesthetics Raises USD5 Million in Venture Financing 11
EternoGen Aesthetics Raises Additional USD0.7 Million in Venture Financing 12
EternoGen Aesthetics Raises USD0.1 Million in Venture Financing 13
Dermelle Raises US$1 Million In Venture Financing 14
EternoGen Aesthetics LLC, Key Competitors 15
EternoGen Aesthetics LLC, Key Employees 16
EternoGen Aesthetics LLC, Other Locations 17

List of Figures
EternoGen Aesthetics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[EternoGen Aesthetics LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eneco Holding NV-エネルギー分野:企業M&A・提携分析
    Summary Eneco Holding N.V. (Eneco) is an integrated energy company. It produces, trades, transmits and supplies gas, electricity and heat. Eneco undertakes the sale, rental, installation, and maintenance of heating and hot water equipment; and maintenance of the electricity, gas and district heat ne …
  • Nutra Pharma Corp (NPHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis …
  • Koncar – Elektroindustrija dd (KOEI-R-A):企業の財務・戦略的SWOT分析
    Summary Koncar - Elektroindustrija dd (Koncar) is an electrical equipment company that designs and develops power transmission, generation, distribution plants, and others. The company provides products such as electric vehicles, hydro power plant, accompanying equipment, electric traction plants, e …
  • Generali France S.A.:企業の戦略・SWOT・財務分析
    Generali France S.A. - Strategy, SWOT and Corporate Finance Report Summary Generali France S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Laboratory Corp of America Holdings (LH):医療機器:M&Aディール及び事業提携情報
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • High Energy Batteries (India) Ltd:企業の戦略・SWOT・財務分析
    High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Societe Generale Private Banking:企業の戦略・SWOT・財務情報
    Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report Summary Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Qisda Corporation
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AMETEK, Inc.:企業の戦略・SWOT・財務情報
    AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Verona Pharma Plc (VRP)-製薬・医療分野:企業M&A・提携分析
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • Intercept Pharmaceuticals Inc (ICPT):企業の財務・戦略的SWOT分析
    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Aviragen Therapeutics Inc (AVIR):企業の財務・戦略的SWOT分析
    Aviragen Therapeutics Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Associated Milk Producers Inc.:企業の戦略・SWOT・財務分析
    Associated Milk Producers Inc. - Strategy, SWOT and Corporate Finance Report Summary Associated Milk Producers Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tokuyama Corp (4043):企業の財務・戦略的SWOT分析
    Tokuyama Corp (4043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BioMarin Pharmaceutical Inc (BMRN):医療機器:M&Aディール及び事業提携情報
    Summary BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals for treatment of serious diseases and medical conditions, such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasi …
  • Regis Healthcare Ltd:企業の戦略・SWOT・財務情報
    Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report Summary Regis Healthcare Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ajinomoto Co Inc (2802):企業の財務・戦略的SWOT分析
    Ajinomoto Co Inc (2802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • HeartSine Technologies LLC:企業の戦略的SWOT分析
    HeartSine Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • GW Pharmaceuticals Plc (GWP):企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Pine Cliff Energy Ltd (PNE):企業の財務・戦略的SWOT分析
    Summary Pine Cliff Energy Ltd (Pine Cliff) is an oil and gas company that offers exploration, production, and development of natural gas, crude oil, and natural gas liquids. The company operates through its core areas such as Edson Assets, Central Assets, and Southern Assets. It acquired Hatton prop …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆